This is a cracker of an announcement, best since the OA trial. Fuji are a contract manufacturing company and were never the ideal partner to run trials and launch a product. The 5M payment to CYP is very significant given the tiny MC. I’m surprised by the lacklustre market response, but this is CYP….
To me this reads CYP are already in discussions with another partner in the USA for GVHD. Hopefully a fully fledged pharmaceutical company with experience in running trials through to FDA approval and marketing.
This is a cracker of an announcement, best since the OA trial....
-
- There are more pages in this discussion • 222 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.005(1.79%) |
Mkt cap ! $50.29M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 27.5¢ | 27.5¢ | $3.441K | 12.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28229 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 134363 | 4 |
View Market Depth
| Last trade - 11.42am 26/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |